Metagenomics Market Size and Share Forecast Outlook 2025 to 2035

The global Metagenomics Market is estimated to be valued at USD 231.1 million in 2025 and is projected to reach USD 442.07 million by 2035, registering a CAGR of 6.7% over the forecast period.

Quick Stats for Metagenomics Market

  • Industry Value (2025): USD 231.1 Million
  • Forecast Value (2035): USD 442.07 Million
  • Forecast CAGR: 6.7%
  • Leading Segment in 2025 (Product): Library Preparation Kits (42.3% share)
  • Key Growth Regions: North America, Asia-Pacific
  • Top Key Players: Illumina Inc, Thermo Fisher Scientific, Trivitron Healthcare, Qiagen, Symbio Scientific Pvt Ltd., Infobio, Bio-Rad laboratories, Merck KgaA, Promega Corporation, Perkin Elmer Inc.

Metagenomics Market Industry Value Analysis

Metric Value
Market Size in 2025 USD 231.1 Million
Projected Market Size in 2035 USD 442.07 Million
CAGR (2025 to 2035) 6.7%

The metagenomics market has witnessed robust expansion as next-generation sequencing and bioinformatics technologies have become integral to understanding complex microbial communities across human, environmental, and industrial ecosystems.

Advances in shotgun sequencing, marker gene analysis, and computational pipelines have enabled precise profiling of unculturable organisms, supporting applications ranging from infectious disease diagnostics to agricultural optimization.

Growing awareness of the microbiome’s role in health and disease has spurred significant research funding and collaborative initiatives among academic institutions, public health agencies, and life science companies. Regulatory frameworks endorsing metagenomic testing for pathogen surveillance and antimicrobial resistance monitoring have further accelerated adoption.

Analyzing Metagenomics Market by Top Investment Segments

Library Preparation Kits Lead Adoption Due to Workflow Efficiency and Compatibility with High-Throughput Sequencing Platforms

Metagenomics Market Analysis By Product

Product Analysis: Library Preparation Kits

In 2025, a revenue shares of 42.3% has been attributed to library preparation kits, highlighting their critical role in enabling high-quality metagenomic data generation. The growth of this segment has been driven by the need for streamlined workflows that reduce hands-on time and variability in sample processing. Kits offering automation compatibility and pre-validated protocols have been widely adopted to improve reproducibility and shorten turnaround times in both research and clinical labs.

Manufacturers have invested in chemistries supporting low-input DNA, degraded samples, and pathogen-rich matrices, expanding their utility across diverse applications. Cost-effective library preparation solutions is expected as metagenomic sequencing becomes an integral part of microbiome studies and infectious disease diagnostics.

Clinical Diagnostics Emerges as a Key Application Due to Growing Use of Metagenomic Sequencing for Pathogen Detection and Precision Medicine

Metagenomics Market Analysis By Application

Clinical Diagnostics contributes a revenue share of 31.9% has been attributed to clinical diagnostics, reflecting the rising use of metagenomic sequencing in identifying infectious agents and characterizing dysbiosis-linked disorders. Adoption has been driven by the capability of unbiased sequencing to detect a broad range of pathogens, including viruses, bacteria, and fungi, in a single assay.

Clinicians have increasingly relied on metagenomics to guide treatment decisions for sepsis, meningitis, and antimicrobial resistance cases where conventional culture-based methods are limited. Regulatory support for validated sequencing workflows has further encouraged clinical deployment. Continued investment in clinical-grade pipelines, reimbursement pathways, and point-of-care solutions is anticipated to support strong growth in this segment.

Pharmaceutical Industries Dominate Use as Companies Leverage Microbiome Insights to Accelerate Drug Discovery and Development

Metagenomics Market Analysis By End User

Pharmaceutical Industries is estimated to be accounting for a revenue share of 26.1% which is attributed to their key role in driving metagenomics adoption for therapeutic innovation. Utilization has been driven by the need to understand host-microbiome interactions, identify novel drug targets, and develop microbiome-based therapeutics and diagnostics.

Companies have incorporated metagenomic data into discovery pipelines to inform biomarker development and stratify patient populations. Strategic collaborations with sequencing platform developers and bioinformatics providers have further strengthened this segment’s growth. Over the forecast period, the expansion of microbiome drug development programs and investment in companion diagnostics are expected to reinforce pharmaceutical industry leadership in the market.

Challenges and Opportunities

Challenges

Data interpretation complexity, standardization gaps, and high infrastructure costs

The inherent complexity of metagenomics data and the requisite advanced computational tools and trained personnel have remained the bigger challenges. The entire range, from sampling to methodology, sequencing protocol, and data interpretation framework, is yet to be standardized across laboratories and contexts of research.

Installation of high-throughput sequencing and computing resources is still devastatingly unaffordable, even for the low and middle-income settings. The World Health Organization calls for the equitable development of global health equity standards for genomic surveillance metagenomics tools.

Opportunities

Personalized microbiome-based medicine, AMR monitoring, and environmental diagnostics

There are emerging opportunities in the personalized health segments such as microbiome-based diagnostics, products development, and therapeutic response prediction. In clinical microbiology, metagenomic sequencing is almost single-handedly revolutionizing the diagnostics for those rare and polymicrobial infections that can simply not be cultured.

The environmental potential areas like soil health monitoring, water quality assessment, and remediation are rapidly on the rise. WHO indicates that providing metagenomics data into the functioning surveillance system of public health and environment could significantly boost the preparedness of the whole world against pandemics and threats related to climate change.

Country-Wise Outlook

Metagenomics Market Cagr Analysis By Country

United States

The metagenomics market in the USA shows an unwavering growth attributable to the advancement in next-generation sequencing (NGS), microbiome study, and infectious disease surveillance. Institutions and biotechnologies are employing metagenomics for applications in drug discovery, environmental monitoring, and precision medicine.

As per OECD, there are federal efforts in support of microbiome and pathology innovation under NIH Human Microbiome Program and grants from DARPA and BARDA. The growing application of metagenomics in agriculture and food safety in terms of microbial diversity assessment can further stimulate growth in this area.

Country CAGR (2025 to 2035)
United States 7.0%

United Kingdom

Much of the advancement of the metagenomics market in the UK takes place on the back of microbial genomic research, AMR (antimicrobial resistance) surveillance, and personalized health, strongly supported by academia and the government.

As per OECD, the United Kingdom is the global leader in genomic medicine, and organizations such as Wellcome Sanger Institute use metagenomics to study gut flora, environmental biodiversity, and zoonotic transmission. NHS-supported genomic projects and public health microbiology programs also expand demand for metagenomic sequencing in clinical and environmental settings.

Country CAGR (2025 to 2035)
United Kingdom 6.5%

European Union

The EU market for metagenomics is gaining traction through investments in food safety, environmental microbiome research, and translational medicine. Germany, France, and the Netherlands are applying metagenomics to monitor wastewater, soil biodiversity, and chronic disease studies.

According to UN data, programs such as Horizon Europe and One Health fund applications of metagenomics in agriculture, human health, and antimicrobial stewardship. EU laboratories are also adopting portable NGS platforms and cloud analysis tools to improve response to microbial surveillance and outbreak.

Country CAGR (2025 to 2035)
European Union 6.7%

Japan

Like any other country, Japan's metagenomics market is maturing steadily, thanks to the applications enhanced by probiotic development, gastrointestinal health, and even fermentation studies. However, the focus of the country towards healthy aging and traditional studies on their diet has motivated the public to be inspired by the gut microbiota profiling and functional genomics.

According to the OECD, investments of the Japanese government and universities are at work with microbial biotechnology platforms, thereby widening the scope of metagenomic studies in basic and clinical research. The food industry is also the largest user of metagenomic tools and applications in the metagenomics arena by ensuring food safety and quality.

Country CAGR (2025 to 2035)
Japan 6.4%

South Korea

The South Korea metagenomics market has been expanded at a fast pace with applications increasingly being applied towards health, agriculture, and bioenvironmental research. National investments towards developing genomic medicine and bioinformatics platforms integrated with AI, as per OECD data, are speeding up the country's lead in precision health.

Research institutes in Korea use metagenomic sequencing to study a number of dimensions including surveillance of hospital-acquired infections, antibiotic resistance genes, and the environmental microbial ecosystem. These are joint public-private partnerships between university and biotech startups for developing innovative microbiome-based diagnostics and therapeutics.

Country CAGR (2025 to 2035)
South Korea 6.9%

Competition Outlook

The competitive landscape has been defined by companies investing in optimized library preparation kits, automated workflows, and bioinformatics platforms. Leading players are expanding portfolios to include complete metagenomic solutions combining sequencing, cloud-based analysis, and regulatory support.

Strategic alliances with hospitals and pharmaceutical companies are fostering validation studies and expanding clinical adoption. Investment in education and training initiatives is helping to drive awareness and accelerate integration into diagnostic labs. These activities are expected to sustain strong competition and continuous innovation in the metagenomics market.

Key Development:

In 2024, MGI Tech has launched its Human Microbiome Metagenomics Sequencing Package, now available for pre-order. This comprehensive solution covers the entire sequencing workflow-from sample collection to analysis-offering high automation and flexible throughput. Validated with numerous biological samples, it's an ideal tool for human microbiome research.

In 2024, Atrandi Biosciences has launched the Flux microfluidic system and Single-Microbe DNA Barcoding Kit. This novel kit enables labeling of up to 10,000 microbial genomes in one experiment for high-throughput genomics. They're also offering a proof-of-concept program for researchers to assess single-cell DNA sequencing.

Companies

  • Illumina Inc,
  • Thermo Fisher Scientific,
  • Trivitron Healthcare,
  • Qiagen,
  • Symbio Scientific Pvt Ltd.,
  • Infobio,
  • Bio-Rad laboratories,
  • Merck KgaA,
  • Promega Corporation,
  • Perkin Elmer Inc.

Key Segmentation

By Product Type:

  • Library Preparation Kits
  • Sample Extraction Kits
  • Metagenomic Sequencing Kits

By Application:

  • Microbial Diversity
  • Bioremediation and Degradation
  • Bio Surfactants and Antibiotics Production
  • Clinical Diagnostics
  • Others

By End User:

  • Pharmaceutical Industries
  • Research Laboratories
  • Biotechnology Companies
  • Pathology Laboratories
  • Academic and Research Institutes

By Region:

  • North America
  • Latin America
  • Europe
  • Japan
  • Asia Pacific
  • The Middle East and Africa

Table of Content

  1. Executive Summary
  2. Industry Introduction, including Taxonomy and Market Definition
  3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
  4. Market Demand Analysis 2020 to 2024 and Forecast 2025 to 2035, including Historical Analysis and Future Projections
  5. Pricing Analysis
  6. Market Analysis 2020 to 2024 and Forecast 2025 to 2035
    • Product Type
    • Application
    • End User
  7. Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Product Type
    • Library Preparation Kits
    • Sample Extraction Kits
    • Metagenomic Sequencing Kits
  8. Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Application
    • Microbial Diversity
    • Bioremediation and Degradation
    • Bio Surfactants and Antibiotics Production
    • Clinical Diagnostics
    • Others
  9. Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By End User
    • Pharmaceutical Industries
    • Research Laboratories
    • Biotechnology Companies
    • Pathology Laboratories
    • Academic and Research Institutes
  10. Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Region
    • North America
    • Latin America
    • Western Europe
    • Eastern Europe
    • East Asia
    • South Asia Pacific
    • Middle East and Africa
  11. North America Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  12. Latin America Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  13. Western Europe Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  14. Eastern Europe Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  15. East Asia Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  16. South Asia Pacific Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  17. Middle East and Africa Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  18. Sales Forecast 2025 to 2035 by Product Type, Application, and End User for 30 Countries
  19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
  20. Company Profile
    • Illumina Inc
    • Perkin Elmer Inc.
    • Trivitron Healthcare Pvt. Ltd.
    • Qiagen N.V.
    • Thermo Fisher Scientific
    • Symbio Scientific Pvt. Ltd.
    • Infobio
    • Bio-Rad Laboratories
    • Merck KgaA
    • Promega Corporation

List of Tables

  • Table 1: Global Market Value (USD million) Forecast by Region, 2020 to 2035
  • Table 2: Global Market Value (USD million) Forecast by Product Type, 2020 to 2035
  • Table 3: Global Market Value (USD million) Forecast by Application, 2020 to 2035
  • Table 4: Global Market Value (USD million) Forecast by End User, 2020 to 2035
  • Table 5: North America Market Value (USD million) Forecast by Country, 2020 to 2035
  • Table 6: North America Market Value (USD million) Forecast by Product Type, 2020 to 2035
  • Table 7: North America Market Value (USD million) Forecast by Application, 2020 to 2035
  • Table 8: North America Market Value (USD million) Forecast by End User, 2020 to 2035
  • Table 9: Latin America Market Value (USD million) Forecast by Country, 2020 to 2035
  • Table 10: Latin America Market Value (USD million) Forecast by Product Type, 2020 to 2035
  • Table 11: Latin America Market Value (USD million) Forecast by Application, 2020 to 2035
  • Table 12: Latin America Market Value (USD million) Forecast by End User, 2020 to 2035
  • Table 13: Europe Market Value (USD million) Forecast by Country, 2020 to 2035
  • Table 14: Europe Market Value (USD million) Forecast by Product Type, 2020 to 2035
  • Table 15: Europe Market Value (USD million) Forecast by Application, 2020 to 2035
  • Table 16: Europe Market Value (USD million) Forecast by End User, 2020 to 2035
  • Table 17: CIS & Russia Market Value (USD million) Forecast by Country, 2020 to 2035
  • Table 18: CIS & Russia Market Value (USD million) Forecast by Product Type, 2020 to 2035
  • Table 19: CIS & Russia Market Value (USD million) Forecast by Application, 2020 to 2035
  • Table 20: CIS & Russia Market Value (USD million) Forecast by End User, 2020 to 2035
  • Table 21: APEJ Market Value (USD million) Forecast by Country, 2020 to 2035
  • Table 22: APEJ Market Value (USD million) Forecast by Product Type, 2020 to 2035
  • Table 23: APEJ Market Value (USD million) Forecast by Application, 2020 to 2035
  • Table 24: APEJ Market Value (USD million) Forecast by End User, 2020 to 2035
  • Table 25: Japan Market Value (USD million) Forecast by Country, 2020 to 2035
  • Table 26: Japan Market Value (USD million) Forecast by Product Type, 2020 to 2035
  • Table 27: Japan Market Value (USD million) Forecast by Application, 2020 to 2035
  • Table 28: Japan Market Value (USD million) Forecast by End User, 2020 to 2035
  • Table 29: MEA Market Value (USD million) Forecast by Country, 2020 to 2035
  • Table 30: MEA Market Value (USD million) Forecast by Product Type, 2020 to 2035
  • Table 31: MEA Market Value (USD million) Forecast by Application, 2020 to 2035
  • Table 32: MEA Market Value (USD million) Forecast by End User, 2020 to 2035

List of Figures

  • Figure 1: Global Market Value (USD million) by Product Type, 2025 to 2035
  • Figure 2: Global Market Value (USD million) by Application, 2025 to 2035
  • Figure 3: Global Market Value (USD million) by End User, 2025 to 2035
  • Figure 4: Global Market Value (USD million) by Region, 2025 to 2035
  • Figure 5: Global Market Value (USD million) Analysis by Region, 2020 to 2035
  • Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2025 to 2035
  • Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2025 to 2035
  • Figure 8: Global Market Value (USD million) Analysis by Product Type, 2020 to 2035
  • Figure 9: Global Market Value Share (%) and BPS Analysis by Product Type, 2025 to 2035
  • Figure 10: Global Market Y-o-Y Growth (%) Projections by Product Type, 2025 to 2035
  • Figure 11: Global Market Value (USD million) Analysis by Application, 2020 to 2035
  • Figure 12: Global Market Value Share (%) and BPS Analysis by Application, 2025 to 2035
  • Figure 13: Global Market Y-o-Y Growth (%) Projections by Application, 2025 to 2035
  • Figure 14: Global Market Value (USD million) Analysis by End User, 2020 to 2035
  • Figure 15: Global Market Value Share (%) and BPS Analysis by End User, 2025 to 2035
  • Figure 16: Global Market Y-o-Y Growth (%) Projections by End User, 2025 to 2035
  • Figure 17: Global Market Attractiveness by Product Type, 2025 to 2035
  • Figure 18: Global Market Attractiveness by Application, 2025 to 2035
  • Figure 19: Global Market Attractiveness by End User, 2025 to 2035
  • Figure 20: Global Market Attractiveness by Region, 2025 to 2035
  • Figure 21: North America Market Value (USD million) by Product Type, 2025 to 2035
  • Figure 22: North America Market Value (USD million) by Application, 2025 to 2035
  • Figure 23: North America Market Value (USD million) by End User, 2025 to 2035
  • Figure 24: North America Market Value (USD million) by Country, 2025 to 2035
  • Figure 25: North America Market Value (USD million) Analysis by Country, 2020 to 2035
  • Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2025 to 2035
  • Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2025 to 2035
  • Figure 28: North America Market Value (USD million) Analysis by Product Type, 2020 to 2035
  • Figure 29: North America Market Value Share (%) and BPS Analysis by Product Type, 2025 to 2035
  • Figure 30: North America Market Y-o-Y Growth (%) Projections by Product Type, 2025 to 2035
  • Figure 31: North America Market Value (USD million) Analysis by Application, 2020 to 2035
  • Figure 32: North America Market Value Share (%) and BPS Analysis by Application, 2025 to 2035
  • Figure 33: North America Market Y-o-Y Growth (%) Projections by Application, 2025 to 2035
  • Figure 34: North America Market Value (USD million) Analysis by End User, 2020 to 2035
  • Figure 35: North America Market Value Share (%) and BPS Analysis by End User, 2025 to 2035
  • Figure 36: North America Market Y-o-Y Growth (%) Projections by End User, 2025 to 2035
  • Figure 37: North America Market Attractiveness by Product Type, 2025 to 2035
  • Figure 38: North America Market Attractiveness by Application, 2025 to 2035
  • Figure 39: North America Market Attractiveness by End User, 2025 to 2035
  • Figure 40: North America Market Attractiveness by Country, 2025 to 2035
  • Figure 41: Latin America Market Value (USD million) by Product Type, 2025 to 2035
  • Figure 42: Latin America Market Value (USD million) by Application, 2025 to 2035
  • Figure 43: Latin America Market Value (USD million) by End User, 2025 to 2035
  • Figure 44: Latin America Market Value (USD million) by Country, 2025 to 2035
  • Figure 45: Latin America Market Value (USD million) Analysis by Country, 2020 to 2035
  • Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2025 to 2035
  • Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2025 to 2035
  • Figure 48: Latin America Market Value (USD million) Analysis by Product Type, 2020 to 2035
  • Figure 49: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2025 to 2035
  • Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2025 to 2035
  • Figure 51: Latin America Market Value (USD million) Analysis by Application, 2020 to 2035
  • Figure 52: Latin America Market Value Share (%) and BPS Analysis by Application, 2025 to 2035
  • Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Application, 2025 to 2035
  • Figure 54: Latin America Market Value (USD million) Analysis by End User, 2020 to 2035
  • Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User, 2025 to 2035
  • Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User, 2025 to 2035
  • Figure 57: Latin America Market Attractiveness by Product Type, 2025 to 2035
  • Figure 58: Latin America Market Attractiveness by Application, 2025 to 2035
  • Figure 59: Latin America Market Attractiveness by End User, 2025 to 2035
  • Figure 60: Latin America Market Attractiveness by Country, 2025 to 2035
  • Figure 61: Europe Market Value (USD million) by Product Type, 2025 to 2035
  • Figure 62: Europe Market Value (USD million) by Application, 2025 to 2035
  • Figure 63: Europe Market Value (USD million) by End User, 2025 to 2035
  • Figure 64: Europe Market Value (USD million) by Country, 2025 to 2035
  • Figure 65: Europe Market Value (USD million) Analysis by Country, 2020 to 2035
  • Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2025 to 2035
  • Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2025 to 2035
  • Figure 68: Europe Market Value (USD million) Analysis by Product Type, 2020 to 2035
  • Figure 69: Europe Market Value Share (%) and BPS Analysis by Product Type, 2025 to 2035
  • Figure 70: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2025 to 2035
  • Figure 71: Europe Market Value (USD million) Analysis by Application, 2020 to 2035
  • Figure 72: Europe Market Value Share (%) and BPS Analysis by Application, 2025 to 2035
  • Figure 73: Europe Market Y-o-Y Growth (%) Projections by Application, 2025 to 2035
  • Figure 74: Europe Market Value (USD million) Analysis by End User, 2020 to 2035
  • Figure 75: Europe Market Value Share (%) and BPS Analysis by End User, 2025 to 2035
  • Figure 76: Europe Market Y-o-Y Growth (%) Projections by End User, 2025 to 2035
  • Figure 77: Europe Market Attractiveness by Product Type, 2025 to 2035
  • Figure 78: Europe Market Attractiveness by Application, 2025 to 2035
  • Figure 79: Europe Market Attractiveness by End User, 2025 to 2035
  • Figure 80: Europe Market Attractiveness by Country, 2025 to 2035
  • Figure 81: CIS & Russia Market Value (USD million) by Product Type, 2025 to 2035
  • Figure 82: CIS & Russia Market Value (USD million) by Application, 2025 to 2035
  • Figure 83: CIS & Russia Market Value (USD million) by End User, 2025 to 2035
  • Figure 84: CIS & Russia Market Value (USD million) by Country, 2025 to 2035
  • Figure 85: CIS & Russia Market Value (USD million) Analysis by Country, 2020 to 2035
  • Figure 86: CIS & Russia Market Value Share (%) and BPS Analysis by Country, 2025 to 2035
  • Figure 87: CIS & Russia Market Y-o-Y Growth (%) Projections by Country, 2025 to 2035
  • Figure 88: CIS & Russia Market Value (USD million) Analysis by Product Type, 2020 to 2035
  • Figure 89: CIS & Russia Market Value Share (%) and BPS Analysis by Product Type, 2025 to 2035
  • Figure 90: CIS & Russia Market Y-o-Y Growth (%) Projections by Product Type, 2025 to 2035
  • Figure 91: CIS & Russia Market Value (USD million) Analysis by Application, 2020 to 2035
  • Figure 92: CIS & Russia Market Value Share (%) and BPS Analysis by Application, 2025 to 2035
  • Figure 93: CIS & Russia Market Y-o-Y Growth (%) Projections by Application, 2025 to 2035
  • Figure 94: CIS & Russia Market Value (USD million) Analysis by End User, 2020 to 2035
  • Figure 95: CIS & Russia Market Value Share (%) and BPS Analysis by End User, 2025 to 2035
  • Figure 96: CIS & Russia Market Y-o-Y Growth (%) Projections by End User, 2025 to 2035
  • Figure 97: CIS & Russia Market Attractiveness by Product Type, 2025 to 2035
  • Figure 98: CIS & Russia Market Attractiveness by Application, 2025 to 2035
  • Figure 99: CIS & Russia Market Attractiveness by End User, 2025 to 2035
  • Figure 100: CIS & Russia Market Attractiveness by Country, 2025 to 2035
  • Figure 101: APEJ Market Value (USD million) by Product Type, 2025 to 2035
  • Figure 102: APEJ Market Value (USD million) by Application, 2025 to 2035
  • Figure 103: APEJ Market Value (USD million) by End User, 2025 to 2035
  • Figure 104: APEJ Market Value (USD million) by Country, 2025 to 2035
  • Figure 105: APEJ Market Value (USD million) Analysis by Country, 2020 to 2035
  • Figure 106: APEJ Market Value Share (%) and BPS Analysis by Country, 2025 to 2035
  • Figure 107: APEJ Market Y-o-Y Growth (%) Projections by Country, 2025 to 2035
  • Figure 108: APEJ Market Value (USD million) Analysis by Product Type, 2020 to 2035
  • Figure 109: APEJ Market Value Share (%) and BPS Analysis by Product Type, 2025 to 2035
  • Figure 110: APEJ Market Y-o-Y Growth (%) Projections by Product Type, 2025 to 2035
  • Figure 111: APEJ Market Value (USD million) Analysis by Application, 2020 to 2035
  • Figure 112: APEJ Market Value Share (%) and BPS Analysis by Application, 2025 to 2035
  • Figure 113: APEJ Market Y-o-Y Growth (%) Projections by Application, 2025 to 2035
  • Figure 114: APEJ Market Value (USD million) Analysis by End User, 2020 to 2035
  • Figure 115: APEJ Market Value Share (%) and BPS Analysis by End User, 2025 to 2035
  • Figure 116: APEJ Market Y-o-Y Growth (%) Projections by End User, 2025 to 2035
  • Figure 117: APEJ Market Attractiveness by Product Type, 2025 to 2035
  • Figure 118: APEJ Market Attractiveness by Application, 2025 to 2035
  • Figure 119: APEJ Market Attractiveness by End User, 2025 to 2035
  • Figure 120: APEJ Market Attractiveness by Country, 2025 to 2035
  • Figure 121: Japan Market Value (USD million) by Product Type, 2025 to 2035
  • Figure 122: Japan Market Value (USD million) by Application, 2025 to 2035
  • Figure 123: Japan Market Value (USD million) by End User, 2025 to 2035
  • Figure 124: Japan Market Value (USD million) by Country, 2025 to 2035
  • Figure 125: Japan Market Value (USD million) Analysis by Country, 2020 to 2035
  • Figure 126: Japan Market Value Share (%) and BPS Analysis by Country, 2025 to 2035
  • Figure 127: Japan Market Y-o-Y Growth (%) Projections by Country, 2025 to 2035
  • Figure 128: Japan Market Value (USD million) Analysis by Product Type, 2020 to 2035
  • Figure 129: Japan Market Value Share (%) and BPS Analysis by Product Type, 2025 to 2035
  • Figure 130: Japan Market Y-o-Y Growth (%) Projections by Product Type, 2025 to 2035
  • Figure 131: Japan Market Value (USD million) Analysis by Application, 2020 to 2035
  • Figure 132: Japan Market Value Share (%) and BPS Analysis by Application, 2025 to 2035
  • Figure 133: Japan Market Y-o-Y Growth (%) Projections by Application, 2025 to 2035
  • Figure 134: Japan Market Value (USD million) Analysis by End User, 2020 to 2035
  • Figure 135: Japan Market Value Share (%) and BPS Analysis by End User, 2025 to 2035
  • Figure 136: Japan Market Y-o-Y Growth (%) Projections by End User, 2025 to 2035
  • Figure 137: Japan Market Attractiveness by Product Type, 2025 to 2035
  • Figure 138: Japan Market Attractiveness by Application, 2025 to 2035
  • Figure 139: Japan Market Attractiveness by End User, 2025 to 2035
  • Figure 140: Japan Market Attractiveness by Country, 2025 to 2035
  • Figure 141: MEA Market Value (USD million) by Product Type, 2025 to 2035
  • Figure 142: MEA Market Value (USD million) by Application, 2025 to 2035
  • Figure 143: MEA Market Value (USD million) by End User, 2025 to 2035
  • Figure 144: MEA Market Value (USD million) by Country, 2025 to 2035
  • Figure 145: MEA Market Value (USD million) Analysis by Country, 2020 to 2035
  • Figure 146: MEA Market Value Share (%) and BPS Analysis by Country, 2025 to 2035
  • Figure 147: MEA Market Y-o-Y Growth (%) Projections by Country, 2025 to 2035
  • Figure 148: MEA Market Value (USD million) Analysis by Product Type, 2020 to 2035
  • Figure 149: MEA Market Value Share (%) and BPS Analysis by Product Type, 2025 to 2035
  • Figure 150: MEA Market Y-o-Y Growth (%) Projections by Product Type, 2025 to 2035
  • Figure 151: MEA Market Value (USD million) Analysis by Application, 2020 to 2035
  • Figure 152: MEA Market Value Share (%) and BPS Analysis by Application, 2025 to 2035
  • Figure 153: MEA Market Y-o-Y Growth (%) Projections by Application, 2025 to 2035
  • Figure 154: MEA Market Value (USD million) Analysis by End User, 2020 to 2035
  • Figure 155: MEA Market Value Share (%) and BPS Analysis by End User, 2025 to 2035
  • Figure 156: MEA Market Y-o-Y Growth (%) Projections by End User, 2025 to 2035
  • Figure 157: MEA Market Attractiveness by Product Type, 2025 to 2035
  • Figure 158: MEA Market Attractiveness by Application, 2025 to 2035
  • Figure 159: MEA Market Attractiveness by End User, 2025 to 2035
  • Figure 160: MEA Market Attractiveness by Country, 2025 to 2035

Frequently Asked Questions

What was the overall size of the metagenomics market in 2025?

The overall market size for the metagenomics market was approximately USD 231.1 million in 2025.

How big is the metagenomics market expected to be in 2035?

The metagenomics market is expected to reach approximately USD 442.07 million by 2035.

What will drive the demand for the metagenomics market during the forecast period?

The demand for metagenomics is rising due to its ability to study every type of microorganism, regardless of whether it can be cultured or not.

List the top 5 countries contributing to the metagenomics market.

The top 5 countries driving the development of the metagenomics market are the United States, China, Germany, Japan, and the United Kingdom.

Which segment in the product type and end-user is expected to lead in the metagenomics market?

Library preparation kits and pharmaceutical & biotechnology company adoption are expected to command significant shares over the assessment period.

Future Market Insights

Metagenomics Market